-
BOE-Backed Genewise Bio Secures RMB 100 Million in Series A Financing for Molecular Diagnostics
•
Genewise Bio, a molecular diagnostics company nurtured by BOE Technology Group, has reportedly secured RMB 100 million in a Series A financing round. Tsing Song Capital led the investment round, with additional investments from Wuhe Capital, Aeonmed, and Pinnacles Medtech. Established in 2021, Genewise Bio has developed a comprehensive independent…
